CosmoInnovations has reached an important commercialisation milestone with SkinGate™ Version 2 entering production as international beauty, skincare and retail organisations progress with product evaluations.
Moving from development into manufacturing represents a significant step in the SkinGate journey. The platform was created to combine real-time skin analysis with controlled delivery of skincare formulations through prefilled POD capsules. Its integrated technologies include thermal activation, dual-wavelength LED phototherapy, vibration and transdermal infusion, creating a connected and personalised skincare experience.
Interest from global beauty companies and retail partners reflects the growing demand for intelligent beauty devices that combine diagnostics, formulation delivery and at-home convenience within a single platform. These evaluations may support a range of future commercial pathways, including international distribution, retail partnerships, licensing, white-labelling and strategic collaboration.
SkinGate Version 2 incorporates improvements developed through years of research, prototyping, industry feedback and engagement with international innovation networks. The commencement of production enables CosmoInnovations to supply evaluation units, support partner discussions and prepare for broader market entry.
For CosmoInnovations, this milestone demonstrates the company’s progression from clinical invention and intellectual-property development towards scalable manufacturing and global commercialisation. It also establishes a foundation for the broader SkinGate platform, including skincare PODs and the expanded SkinGate PRO technology.
